Apyx Medical Inc

NASDAQ APYX

Download Data

Apyx Medical Inc Cash to Debt Ratio for the year ending December 31, 2023: 1.30

Apyx Medical Inc Cash to Debt Ratio is 1.30 for the year ending December 31, 2023. The cash to debt ratio assesses a company's ability to cover its total debt obligations with its available cash. It is calculated by dividing cash by total debt. This ratio indicates the company's liquidity and its capacity to meet its debt obligations using its cash reserves. A higher cash to debt ratio suggests a stronger ability to cover debts with cash resources.
NASDAQ: APYX

Apyx Medical Inc

CEO Mr. Charles D. Goodwin II
IPO Date Jan. 1, 1987
Location United States
Headquarters 5115 Ulmerton Road, Clearwater, FL, United States, 33760
Employees 252
Sector Healthcare
Industry Medical devices
Description

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Similar companies

SRDX

SurModics Inc

NA

NA

AXGN

Axogen Inc

NA

NA

OFIX

Orthofix Medical Inc

NA

NA

StockViz Staff

September 20, 2024

Any question? Send us an email